DIAGNOSTIC SYSTEM FOR HEMOGLOBIN ANALYSIS

IMMUNOTHERAPY

Peptides And Method

METHOD FOR MEASURING MINERALOCORTICOID RECEPTOR ACTIVITY

METHODS FOR DETECTING B-ISOX PRECIPITATES OR CAPTURED PROTEINS AS BIOFLUID BIOMARKERS FOR DIFFERENTIAL DIAGNOSTIC, PATHOPHYSIOLOGY MONITORING OR PRESYMPTOMATIC DIAGNOSTIC OF PREDIABETES, DIABETES AND CANCERS

RATIO BETWEEN LTA4H AND METRNL IN THE ASSESSMENT OF POLYCYSTIC OVARIAN SYNDROME

SENSORS FOR 3-HYDROXYBUTYRATE DETECTION

DOC2B AS A BIOMARKER FOR TYPE 1 AND TYPE 2 DIABETES

QUANTIFICATION OF LIPOPROTEIN SUBFRACTION BY ION MOBILITY

URINARY BRANCHED-CHAIN AMINO ACIDS (UBCAAS) AS INSULIN RESISTANCE BIOMARKERS

METHODS AND KITS FOR DETECTION OF AMYLIN-BETA AMYLOID CO-AGGREGATION

Methods for Prognosing Type 1 Diabetes Treatments

METHODS FOR QUANTITATION OF INSULIN AND C-PEPTIDE

METHODS FOR PREDICTION AND EARLY DETECTION OF DIABETES

METHODS AND APPARATUS FOR MEASURING INSULIN RESISTANCE BY DETECTION OF NORMAL AND ABNORMAL INSULIN ISOMERS AND MODULATION OF INSULIN RESISTANCE TREATMENT

APOB:CFAS CONTENT TO AID IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES

SYSTEMS, DEVICES AND METHODS FOR SENSING BIOMARKERS USING ENZYMATIC AND IMMUNOSENSING ELECTROCHEMICAL DETECTION TECHNIQUES

Diabetes Biomarkers

Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases

BIOMARKERS FOR PREDICTING TYPE 2 DIABETES STATUS

CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE

Method and System for the Safety, Analysis, and Supervision of Insulin Pump Action and Other Modes of Insulin Delivery in Diabetes

BIOMARKERS FOR EARLY DETECTION OF DIABETES

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

ORGANIC GLUCOSE BEVERAGE AND GLUCOSE MONITORING SYSTEM FOR DIABETES SCREENING AND DIAGNOSIS

METHODS OF IDENTIFYING SUBJECTS RESPONSIVE TO TREATMENT FOR AN AUTOIMMUNE DISEASE AND COMPOSITIONS FOR TREATING THE SAME

BIOMARKERS FOR DETECTING SYNOVIAL JOINT DISEASE IN MUCOPOLYSACCHARIDOSES

SHBG AND IBP4 ANTIBODIES AND METHODS USING SAME

Method of Predicting the Likelihood of Hyperglycemia

SELECTION BIOMARKERS FOR PATIENT STRATIFICATION IN BODILY FLUIDS AND APPLYING PRECISION MEDICINE THROUGH NOVEL DIAGNOSTIC BIOMARKERS

DETECTION OF GLYCATED ALBUMIN IN DIABETES-AFFECTED BIOLOGICAL SAMPLES

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF

Methods and Kits for Determining Insulin Resistance Treatment

Method for survival prediction and for diagnosis and treatment of Type 2 Diabetes mellitus

METHODS FOR ASSESSING TREATMENT WITH A GASTROINTESTINAL IMPLANT

METHODS FOR QUANTITATION OF INSULIN AND C-PEPTIDE

A BLOOD PROFILE ANALYSIS METHOD FOR IDENTIFICATION OF NEW DIABETES DIAGNOSTIC MARKERS IN SARS-COV-2 INFECTED PATIENTS

SYSTEM AND METHOD FOR CELL LEVITATION AND MONITORING

Methods for Diagnosing and Treating Ischemic Eye Disease

BROWN ADIPOCYTE PROGENITORS IN HUMAN SKELETAL MUSCLE

IGFR-LIKE 2 RECEPTOR AND USES THEREOF

METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS

PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS

Patient Profiling for Antigen-Specific Immunomodulatory Therapies

Data acquisition and analysis method based on diabetes data analysis and processing equipment

Individualized Cell Therapy Using Patient-Derived Antigen-Specific Regulatory T Cells

METHOD FOR TREATING OBESITY, DIABETES, CARDIOVASCULAR AND KIDNEY DISEASES BY REGULATING GPR30/GPER ACTIVITY

Compositions and Methods for Identifying and Modulating Metabolic Health

VITAMIN C RENAL LEAK AS A CLINICAL DIAGNOSTIC TOOL IN THE DETECTION, MONITORING, AND MANAGEMENT OF ACUTE AND CHRONIC DISEASES

DIAGNOSTIC ASSAY FOR CLASSIC INBORN GALACTOSEMIA

ANALYTICAL METHOD FOR GLYCOSAMINOGLYCANS

HUMORAL ANTIBODY BIOMARKER FOR DETECTING ARTERY LESIONS, AND DETECTING CEREBROVASCULAR AND CARDIOVASCULAR DISORDER, DIABETES, CHRONIC NEPHROPATHY, OR SOLID CANCER

ANTI-APRIL ANTIBODIES AND USES THEREOF

NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF

METABOLIC PROFILE SCREENING FOR GESTATIONAL DIABETES

PECVD coated pharmaceutical packaging

CANCER EXAMINATION METHOD AND CANCER TREATMENT AGENT

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

MACROCYCLIC COMPOUNDS

MARKERS FOR PREDICTING POSSIBLITIES OF SUBJECTS WITH DIABETES AND USE THEREOF

Proinsulin Peptides for Type I Diabetes

Diabetes Biomarkers

METHODS AND KITS OF ASSESSING STATUS, RISK OR PROGNOSIS OF TYPE 1 DIABETES

Method and system for rapid prediction offast blood glucose level in pregnant subjects

TEST KIT AND METHOD OF DETERMINING TRYPTOPHAN IN EXTRACTS OF FAECAL SAMPLES

QUANTIFICATION METHOD FOR MODIFIED HDL, AND ANALYSIS REAGENT FOR USE IN SAME METHOD

Integrated Biomarker System for Evaluating Risks of Impaired Fasting Glucose (IFG) and Type 2 Diabetes Mellitus (T2DM)

MARKERS FOR PREDICTING POSSIBILITIES OF SUBJECTS WITH DIABETES AND USE THEREOF

FOLLICULAR HELPER T CELL PROFILE FOR IDENTIFYING PATIENTS WITH TYPE 1 DIABETES SUITABLE FOR TREATMENT WITH CTLA-4-IG

METHOD FOR QUANTIFYING ADIPONECTIN AND ANALYTICAL REAGENT USED THEREOF

METHOD FOR DETERMINING WHETHER A SUBJECT HAS A DISEASE OR CONDITION OR IS AT RISK OF DEVELOPING A DISEASE OR CONDITION

BIOMARKER IN BLOOD FOR MACULAR EDEMA AND USE THEREOF

THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF

METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY

COMPOSITIONS AND METHODS FOR DIABETES TREATMENT

SENSORS FOR 3-HYDROXYBUTYRATE DETECTION

Methods for monitoring physiological status of a body organ

Blood biomarkers and diagnostic methods for small vessel diseases

Compositions and methods for treating age-related diabetes and related disorders

ANTI-IDE ANTIBODIES AND USES OF SAME

Methods of Determining Impaired Glucose Tolerance

METHODS AND COMPOSITIONS FOR TREATING TYPE 2 DIABETES

NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF

DIABETES THERAPY TARGETING ABNORMAL STEM CELLS

METHODS AND KITS FOR DETECTING AUTOIMMUNE DISEASES

USE OF ITIH1 AS BIOMARKER FOR DETECTION OF INSULIN RESISTANCE IN DISEASES ACCOMPANIED BY IMPAIRED GLUCOSE TOLERANCE

METHOD AND SYSTEM FOR PREDICTING GESTATIONAL DIABETES

CORRECTING PROTEIN MISFOLDING IN DIABETES

Devices and Methods for Female Health Monitoring

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF METABOLIC DISEASES AND DISORDERS

METHODS AND COMPOSITIONS FOR TREATING OBESITY AND/OR DIABETES AND FOR IDENTIFYING CANDIDATE TREATMENT AGENTS

METHOD OF USING FOLLISTATIN IN TYPE 2 DIABETES RISK PREDICTION

PECVD coated pharmaceutical packaging

LAMA2, PLXDC2 AND MLL4 AS NOVEL BIOMARKERS FOR PREDIABETES AND DIABETES

SYSTEMS, DEVICES AND METHODS FOR SENSING BIOMARKERS USING ENZYMATIC AND IMMUNOSENSING ELECTROCHEMICAL DETECTION TECHNIQUES

Glycated CD59 peptides, their preparation, and uses thereof

COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS

Test strip code reader and analyte detection device

Physiological signal monitoring device

Disease-associated antigens and methods of use thereof

Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

TMA-formation inhibitor treatment for elevated TMA-containing compound diseases

NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF

BIOMARKERS FOR TYPE 1 DIABETES

Methods for quantitation of insulin and C-peptide

METHODS OF DETECTION AND TREATMENT FOR CARDIOVASCULAR DISEASE AND FOOT WOUNDS

Diagnostic methods, therapeutic agents and uses thereof

SYSTEM FOR DETECTING A PATHOLOGY OF A CAT

METHOD FOR DIAGNOSIS AND TREATING PERIPHERAL NEUROPATHIES

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF

MARKERS OF RISK TO DEVELOP INSULIN RESISTANCE DURING CHILDHOOD AND YOUNG ADULTHOOD

System and method for cell levitation and monitoring

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

IMMUNOASSAY FOR MEASURING C-PEPTIDE

Methods for improving cardiovascular disease management

METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes

DOC2B AS A BIOMARKER FOR TYPE 1 AND TYPE 2 DIABETES

Anti-CD59 antibodies

Compositions and methods for identifying and modulating metabolic health

LATERAL FLOW ASSAY SYSTEMS AND METHODS FOR THE QUANTIFICATION OF A BIOLOGICAL SAMPLE

ZnT8 assays for drug development and pharmaceutical compositions

Metal nanoparticles for glucose detection and glucose detection method using the same

DETECTION OF 1, 5-ANHYDROGLUCITOL (1, 5-AG) IN SALIVA

METHODS OF ESTIMATING BLOOD GLUCOSE AND RELATED SYSTEMS

PROTEIN BIOMARKERS FOR NEPHROPATHY AND APPLICATIONS THEREOF

Thermostabilized Amadoriases and uses thereof

Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

Inhibitor of IGFBP3/TMEM219 Axis and Diabetes

METHOD FOR MEASURING THE TRIMETHYLAMINE N-OXIDE PRODUCTION CAPACITY IN AN INDIVIDUAL

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES AS BIOMARKER FOR GESTATIONAL DIABETES MELLITUS

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

ANALYTICAL METHOD FOR GLYCOSAMINOGLYCANS

DIABETES-RELATED BIOMARKERS AND TREATMENT OF DIABETES-RELATED CONDITIONS

Determination method and kit for determining possibility of reduced renal function

BREATH TEST DEVICE AND METHOD

Method of determining composition effective for treating diabetes

Means and methods for determining risk of type-1 diabetes by serum protein biomarkers

IMPROVED IMMUNOTHERAPY

Compositions and methods to modulate cell activity

GLYCATED HEMOGLOBIN MEASUREMENT

METHOD FOR DETERMINING THE ANTIOXIDANT CAPACITY OF A BIOLOGICAL SAMPLE AND RELATED KIT

METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER

Compositions for and methods of diagnosing, prognosing, and treating diabetes

DETECTION OF OLIGOSACCHARIDES

Method of detecting and diagnosing the progression of diabetes

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES

DOC2B AS A BIOMARKER FOR TYPE 1 DIABETES

SILICA NANOPARTICLES FOR BIOMARKER DIAGNOSIS AND METHOD FOR PRODUCING SAME

MACROCYCLIC COMPOUNDS

THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c

Method of examining diabetic complication

USE OF TETRASPANIN-2 FOR TREATING DIABETES AND SCREENING AN ANTI-DIABETIC AGENT

Use of the IL-6 gene expression level for classification of a subject in risk groups in the prognosis or diagnosis of type II diabetes mellitus

Brown adipocyte progenitors in human skeletal muscle

THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c

DETECTION OF INSULIN IN SALIVA AND METHODS OF USE THEREOF

Methods for prediction and early detection of diabetes

Method for determining sensitivity to SGLT2 inhibitor and sensitivity marker for SGLT2 inhibitor

METHOD FOR PREDICTING THE RISK OF A SUBJECT FOR CONTRACTING DIABETES MELLITUS AND/OR METABOLIC SYNDROME OR FOR DIAGNOSING METABOLIC SYNDROME IN A SUBJECT

DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES

Selection biomarkers for patient stratification in bodily fluids and applying precision medicine through novel diagnostic biomarkers

ApoCIII and the Treatment and Diagnosis of Diabetes

DIAGNOSTIC AND THERAPEUTIC METHODS FOR TYPE 2 DIABETES

Thermostable glucose biosensors and uses thereof

INTERLEUKIN 32 AS A BIOMARKER OF TYPE 1 DIABETES

A METHOD FOR DETERMINING MYELOID NATURAL KILLER (NK)-CELLS AND USE THEREOF

Application of anti-CD39L3 antibodies for use in disease diagnostics and imaging

Process and apparatus for manufacturing water-absorbing material and use in cat litter

Methods for diagnosis of type 1 diabetes

MARKERS IN PREPUBERTY FOR CHILDHOOD-PREDIABETES

Cell-Free microRNA Signatures of Pancreatic Islet Beta Cell Death

Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

Diagnosis of diabetes by detecting aggregated amylin in erythrocytes

Compositions and methods for treating age-related diabetes and related disorders

Flattop (fltp) is a novel biomarker for beta cell maturation

Proteoliposome-based ZnT8 self-antigen for type 1 diabetes diagnosis

METHOD FOR DETERMINING THE RISK TO DEVELOP TYPE 1 DIABETES

Compositions for differentiating latent autoimmune diabetes in adults from childhood-onset type 1 diabetes and methods for diagnosing and treating disease

GALACTOSE RAPID QUANTITATIVE DETECTION SYSTEM AND USE THEREOF

Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

DIAGNOSTIC METHODS, THERAPEUTIC AGENTS AND USES THEREOF

METHOD FOR OBTAINING INFORMATION ON SUBJECT'S DIABETES

BLOOD BIOMARKERS AND DIAGNOSTIC METHODS FOR SMALL VESSEL DISEASES

Methods for assessing treatment with a gastrointestinal implant

Compositions and methods for regulating pancreatic beta cell function using adipsin

Methods and systems for diagnosing diseases

Methods of diagnosing and predicting renal disease

ENZYMATIC ASSAYS FOR QUANTIFYING THERAPY IN SUBJECTS WITH MUCOPOLYSACCHARIDOSIS TYPE I OR II

Tracking the Probability for Imminent Hypoglycemia in Diabetes From Self-Monitoring Blood Glucose (SMBG) Data

Nanoparticle probes and methods of making and use thereof

SUBSTRATES RECOGNIZED BY FIBROBLAST ACTIVATION PROTEIN (FAP) AND METHODS OF USING THE SAME

Natural Drink Used in Medical Diagnosis

Methods for Identifying and Treating Mammalian Subjects with Insulin Resistance

Macrocyclic compounds

Diagnostics Platform for Mitochondrial Dysfunctions/Diseases

METHOD FOR PREDICTING THE DEVELOPMENT OF TYPE 2 DIABETES

Tissue-specific exosomes as biomarkers

Compositions and methods for identifying metabolically active agents

METABOLIC DISORDERS

Methods for evaluating glycemic regulation and applications thereof

Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome

Compositions and methods for treating chemosensory dysfunction

COMPOSITIONS AND METHOD FOR DETERMINING INSULIN RESISTANCE USING NON-ESTERIFIED FATTY ACID ANALYSIS

In vitro method for identifying a pregnancy related disease

BIOTHIOL DETECTION COMPOSITION COMPRISING REDOX REGULATION PROTENIN

Method of evaluating hepatic glucose uptake capacity

Single-channel, hybrid biosensor and sensor system including the same

Insulin mimotopes and methods of using the same

Tracking changes in average glycemia in diabetics

Methods for monitoring physiological status of a body organ

NON-POLYAMINATED LCN2 AS A BIOMARKER FOR DIAGNOSIS AND TREATMENT OF CARDIOMETABOLIC DISEASES

Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy

ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF

Enolase 1 (ENO1) compositions and uses thereof

METHOD FOR TESTING NK CELL ACTIVITY USING SYNERGISTIC ACTIVITY OF RECEPTOR, AND METHOD FOR DIAGNOSING DISEASE ASSOCIATED WITH NK CELL ACTIVITY USING SAME

Methods for quantitation of insulin levels by mass spectrometry

ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS

Diabetes-related biomarkers and treatment of diabetes-related conditions

GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS

Reagent composition for measuring glycated hemoglobin and method for measuring glycated hemoglobin using same

Glucose sensing contact lens

Non-invasive photonic sensing for monitoring diabetes

BLOOD SAMPLE ANALYSIS METHOD AND SYSTEM, FOR DETERMINING DIABETES

METHOD FOR DETERMINING ALZHEIMER'S DISEASE RISK

Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss

METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF

Method For Quantifying Plasmalogens Using PLA1 Processing

Trimethylamine-containing compounds for diagnosis and prediction of disease

Procalcitonin for the prognosis of adverse events

Extracellular vesicle ribonucleic acid (RNA) cargo as a biomarker of hyperglycemia and type 1 diabetes

Compositions and methods for measuring NMU and for treatment using anti-NMU agents

METHODS AND USES OF MITOFUSINS

Procedure of predicting type 2 diabetes development through analysis of N-glycans attached to the plasma proteins of a healthy person

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Measurement of glycoprotein

System and method for determining risk of diabetes based on biochemical marker analysis

BIOMARKERS OF METHYLGLYOXAL AND RELATED METHODS THEREOF

Measurement of glycoprotein

ZNT8 assays for drug development and pharmaceutical compositions

DIABETES BIOMARKERS

Glucagon/GLP-1 receptor co-agonists

Method for Identifying an Agent for Treating Abnormal Kidney Function

METHOD OF DETECTION OF CLINICALLY SIGNIFICANT POST-PRANDIAL HYPERGLYCEMIA IN NORMOGLYCEMIC PATIENTS

Disease-associated antigens and methods of use thereof

Physiologic insulin-sensitivity improvement

INDIRECT ASSESSMENT OF INSULIN RELEASE IN A CELL

Methods for quantitation of insulin and C-peptide

Methods for monitoring physiological status of a body organ

METHOD FOR DETECTING DISEASE

Methods for Early Diagnosis of Kidney Disease

METHODS AND KITS OF ASSESSING STATUS, RISK OR PROGNOSIS OF TYPE 1 DIABETES

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES

Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents

Methods of estimating blood glucose and related systems

Methods for treatment of oncological disorders using an epimetabolic shifter (Coenzyme Q10)

ANTIBODIES, COMPOUNDS AND SCREENS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA

ApoCIII and the Treatment and Diagnosis of Diabetes

CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease

Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof

Methods of quantifying N-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG

METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

FOOD INTAKE, BODY WEIGHT AND GLUCOSE METABOLISM REGULATION BY MODULATION OF P2Y6 RECEPTOR SIGNALING

Soluble MANF in pancreatic beta-cell disorders

Method and product for testing response to oral glucose load

Methods of detection and treatment for cardiovascular disease and foot wounds

Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

Device and method for automatic data acquisition and/or detection

METHODS FOR IMPROVING DIABETES MANAGEMENT

Solid Phase Assay for Detecting Biomarkers for Cardiodiabetes

Method for measuring tyrosine phosphatase and tyrosine kinase activity

Portable insulin resistance diagnosis device and diagnosis method using same

Method for quantifying plasmalogens using PLA1 processing

Systems and methods for the detection of HbA1c

Hyperglycemic Sensor Apparatus for Breath Gas Analysis

Compositions and methods for treating age-related diabetes and related disorders

Glycated CD59 peptides, their preparation, and uses thereof

Cell encapsulation device

In vitro method for identifying a pregnancy related disease

Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c

Diagnostic method and biomarker for lifestyle disease

Method for measuring glycated protein using interdigitated electrode

Inhibitor of IGFBP3/TMEM219 axis and diabetes

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

Process and apparatus for manufacturing water-absorbing material and use in cat litter

GLYCEROL-3-PHOSPHATE PHOSPHATASE ACTIVATORS

Multi-peptide composition

Measurement method and measurement device

Three-dimensional co-culture method for adipocytes and macrophages

Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same

Methods of quantifying N-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG

Biomarkers Related to Insulin Resistance Progression and Methods Using the Same

Compositions and methods to modulate cell activity

Chimeric fibroblast growth factor 21 proteins and methods of use